​

Organon (OGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

OGN Stock Forecast

Organon (OGN) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $24.00, with a high of $24.00 and a low of $24.00. This represents a 51.52% increase from the last price of $15.84.

$14 $16 $18 $20 $22 $24 High: $24 Avg: $24 Low: $24 Last Closed Price: $15.84

OGN Stock Rating

Organon stock's rating consensus is Hold, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (33.33%), 2 Hold (66.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 3 0 2 1 Strong Sell Sell Hold Buy Strong Buy

OGN Forecast vs Benchmarks

TypeNameUpside
StockOrganon51.52%
SectorHealthcare Stocks 25.20%
IndustryDrug Manufacturers - General Stocks22.62%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$24.00
Last Closing Price$15.84$15.84$15.84
Upside/Downside--51.52%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25313-29
Dec, 24313-29
Nov, 243442215
Oct, 243452216
Sep, 243452216
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 29, 2024David AmsellemPiper Sandler$24.00$18.8527.32%51.52%
Jun 26, 2023David AmsellemPiper Sandler$34.00$20.3766.91%114.65%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Dec 17, 2024Goldman SachsNeutralNeutralhold
Apr 29, 2024Piper SandlerOverweightOverweighthold
Mar 13, 2024Piper SandlerOverweightOverweighthold
Jan 12, 2024Piper SandlerOverweightOverweighthold
Dec 12, 2023Piper SandlerOverweightOverweighthold
Nov 09, 2023Piper SandlerOverweightOverweighthold
Jun 08, 2023Morgan StanleyEqual-WeightEqual-Weighthold
May 09, 2023Morgan StanleyEqual-WeightEqual-Weighthold
Sep 06, 2022Piper SandlerOverweightupgrade
Apr 27, 2022Goldman SachsBuyinitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.33$3.61$3.99-----
Avg Forecast$6.28$4.98$4.07$4.11$4.10$4.34$4.49$4.55
High Forecast$6.19$4.85$3.97$4.06$3.63$4.19$4.34$4.40
Low Forecast$6.38$5.16$4.37$4.18$4.42$4.55$4.70$4.77
Surprise %-15.13%-27.51%-1.97%-----

Revenue Forecast

$6B $6B $6B $6B $7B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.30B$6.17B$6.26B-----
Avg Forecast$6.27B$6.18B$6.21B$6.41B$6.43B$6.52B$6.46B$6.50B
High Forecast$6.20B$6.06B$6.18B$6.40B$6.34B$6.52B$6.29B$6.34B
Low Forecast$6.35B$6.35B$6.26B$6.42B$6.50B$6.52B$6.70B$6.75B
Surprise %0.47%-0.17%0.79%-----

Net Income Forecast

$750M $930M $1B $1B $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.35B$917.00M$1.02B-----
Avg Forecast$1.61B$969.57M$1.02B$1.06B$1.03B$1.12B$1.15B$1.17B
High Forecast$1.59B$775.66M$818.40M$1.04B$930.46M$1.07B$1.11B$1.13B
Low Forecast$1.63B$1.16B$1.23B$1.07B$1.13B$1.17B$1.21B$1.22B
Surprise %-16.08%-5.42%------

OGN Forecast FAQ

Is Organon stock a buy?

Organon stock has a consensus rating of Hold, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Organon is a neutral investment for most analysts.

What is Organon's price target?

Organon's price target, set by 3 Wall Street analysts, averages $24 over the next 12 months. The price target range spans from $24 at the low end to $24 at the high end, suggesting a potential 51.52% change from the previous close price of $15.84.

How does Organon stock forecast compare to the average forecast of its sector, industry, and investment themes?

Organon stock forecast shows a 51.52% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the drug manufacturers - general stocks industry (22.62%).

What is the breakdown of analyst ratings for Organon over the past three months?

  • January 2025: 33.33% Strong Buy, 11.11% Buy, 33.33% Hold, 0% Sell, 22.22% Strong Sell.
  • December 2024: 33.33% Strong Buy, 11.11% Buy, 33.33% Hold, 0% Sell, 22.22% Strong Sell.
  • November 2024: 20.00% Strong Buy, 26.67% Buy, 26.67% Hold, 13.33% Sell, 13.33% Strong Sell.

What is Organon’s EPS forecast?

Organon's average annual EPS forecast for its fiscal year ending in December is 4.11 for 2024, a 3.01% increase from the reported $3.99 in 2023. The prediction for 2025 is $4.1, $4.34 for 2026, $4.49 for 2027, and $4.55 for 2028.

What is Organon’s revenue forecast?

Organon's average annual revenue forecast for its fiscal year ending in December is $6.41B for 2024, a 2.29% increase from the reported $6.26B in 2023. The forecast for 2025 is $6.43B, $6.52B for 2026, $6.46B for 2027, and $6.5B for 2028.

What is Organon’s net income forecast?

For its fiscal year ending in December, Organon's average annual net income forecast is $1.06B for 2024, reflecting an 3.18% increase from the reported $1.02B in 2023. The projection for 2025 is $1.03B, $1.12B for 2026, $1.15B for 2027, and $1.17B for 2028.